Variant 1: Device selection: Acutely ill patient requiring infusion of vesicant medication, hemodynamic monitoring, and frequent blood draws for 2 weeks or shorter.
Variant 2: Device selection: Patient with acute renal failure requiring central venous access for renal replacement therapy, anticipated duration of therapy for 2 weeks or shorter.
Variant 3: Device selection: Patient with renal failure requiring central venous access for renal replacement therapy, anticipated duration of therapy for more than 2 weeks.
Variant 4: Device selection: Patient with cancer diagnosis requiring central venous access for weekly chemotherapy infusion for more than 2 weeks.
Variant 5: Device selection: Patient requiring continuous or very frequent intravenous administration of intravenous medications (excluding total parenteral nutrition) for more than 2 weeks.
Variant 6: Device selection: Patient requiring long-term total parenteral nutrition and another indication for central access.
Variant 7: Device selection: Patient with chronic kidney disease requiring central venous catheter IV infusions for more than 2 weeks.
Variant 8: Site selection: Patient with acute illness requiring central venous catheter for anticipated therapy for 2 weeks or shorter.
Variant 9: Site selection: Patient with chronic kidney disease or end-stage renal disease requiring central venous catheter.
Appendix Key

A more complete discussion of the items presented below can be found by accessing the supporting documents at the designated hyperlinks.

Appropriateness Category:The panel’s recommendation for a procedure based on the assessment of the risks and benefits of performing the procedure for the specified clinical scenario.

SOE: Strength of Evidence. The assessment of the amount and quality of evidence found in the peer reviewed medical literature for an appropriateness recommendation.

  • References: The citation number and PMID for the reference(s) associated with the recommendation.
  • Study Quality: The assessment of the quality of an individual reference based on the number of study quality elements described in the reference.

RRL: Relative Radiation Level. A population based assessment of the amount of radiation a typical patient may be exposed to during the specified procedure.

Rating: The final rating (1-9 scale) for the procedure as determined by the panel during rating rounds.

Median: The median rating (1-9 scale) for the procedure as determined by the panel during rating rounds.

Final tabulations: A histogram showing the number of panel members who rated the procedure as noted in the column heading (ie, 1, 2, 3, etc.).

Additional supporting documents about the AC methodology and processes can be found at www.acr.org/ac.